Get The Jump On Next Week With These 4 Trending Small Cap Stocks

NEW YORK, NY / ACCESSWIRE / April 22, 2016 / The OTC Expert is issuing a report on four stocks that are trading with heavier than usual volume. CBYL, UNXL, CLDX and BCEI are on high volume watch. Continue reading to find out why these stocks are getting so much interest today. – If you want reports on the day’s hottest stocks (NYSE/Nasdaq/OTC) subscribe to our newsletter at otc-expert.com.

Carbylan Therapeutics, Inc. (NASDAQ: CBYL) The company is a specialty pharmaceutical company, focuses on the development and commercialization of novel and proprietary combination therapies.

Shares of CBYL traded higher yesterday by 30.77% after announcing last week that it has suspended further clinical development of Hydros-TA and that it is actively pursuing a strategic transaction, including a merger or acquisition of the company.

However, pre-market today, the stock is giving back 7% of those gains, we are still following this tiny biotech to see if it can hold onto most of these gains going into next week.

Subscribe Free To Receive Alerts Like These Sent To Your Inbox Get Your Free Membership Now.

Uni-Pixel, Inc. (NASDAQ: UNXL) Is a pre-production stage company, engages in developing performance engineered film (PEF) products for the display, touch screen, and flexible electronics market segments in the United States.

We’ve been following the progress of UNXL since the announcement that it received a new design win from a leading U.S. PC manufacturer for a 13.3-inch laptop computer.

This is the fourth win in a string of victories for the fast growing company in 2016. We will continue to watch this growing company as it continues to land major clients.

Like What You See? Get These Alerts and Many More on NASDAQ Companies before They Rally, Find Out More Here.

Celldex Therapeutics, Inc. (NASDAQ: CLDX) Is a biopharmaceutical company, develops, manufactures, and commercializes novel therapeutics for human health care in the United States.

Shares of CLDX have been trading higher after announcing three poster presentations at the American Association for Cancer Research (AACR) Annual Meeting 2016 in New Orleans on Wednesday.

The stock is trading higher pre-market this morning by half a percent, however, we are looking forward to see if CLDX can announce anymore good news before next week.

Get the Information You Need To Stay Informed and Up To Date On The Hottest NASDAQ Plays Get Them Here.

Bonanza Creek Energy, Inc. (NYSE: BCEI) an independent energy company, engages in the acquisition, exploration, development, and production of onshore oil and associated liquids-rich natural gas in the United States.

Over the last 5 trading days, BCEI has been hot, trading higher in each of them. It appears that shares are trading higher pre-market today as well.

However, BCEI has a long road ahead to get back to its 52 week high of $27.95, at least the stock is beginning to show some strength amid the recent bump in oil prices.

NASDAQ Stock Alerts: Check Them Out Here To Receive Our Winning NASDAQ & NYSE Stock Alerts For Free.

About otc-expert.com

The OTC Expert is a newsletter alert service that focuses on companies on the NASDAQ & NYSE. We only highlight quality companies with big news on high volume days. This commitment provides our subscribers with only the best recommendations of companies for short and long-term investments.

To receive free text message alerts on your phone, compose a new text message to the number 95577 with the word “OTCLEADER”.

Disclosure: The information, opinions and analysis contained in this report are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We do not accept any responsibility or liability for any losses, damages or costs arising from an investor’s or other person’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities, nor a recommendation of any security. Past gains are not representative of future gains. The OTC Expert has not been compensated nor does it expect to receive any compensation for distribution of its opinions and publicly available information regarding the companies reported in this investment opinion article at this time. The opinions contained herein contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. When used herein, the words “anticipate,” “intend,” “estimate,” “believe,” “expect,” “plans,” “should,” “potential,” “forecast,” and variations of such words and similar expressions are intended to identify forward-looking statements. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A company’s actual results could differ materially from those described in any forward-looking statements contained herein. The OTC Expert is not a licensed broker, broker dealer, market maker, investment advisor, analyst or underwriter. We recommend that you use the information found herein as an initial starting point for conducting your own research in order to determine your own personal opinion of the companies discussed herein before deciding whether or not to invest. You should seek such investment, tax, financial, accounting or legal advice appropriate for your particular circumstances. Information about many publicly traded companies and other investor resources can be found at www.sec.gov. Investing in securities is speculative and carries risk. Please visit otc-expert.com/disclaimer website for a more detailed discussion of risks and disclosures.

Contact:

Justin Skibinski
The OTC Expert
info@otc-expert.com

SOURCE: The OTC Expert

ReleaseID: 439114